393
Views
0
CrossRef citations to date
0
Altmetric
Editor's Preview

In this issue of Adipocyte

A surprise source of adiponectin

pp. 251–269

The hormone adiponectin facilitates beneficial cardiovascular and metabolic effects, and circulatory levels of this adipocyte-derived hormone are low in obesity as well as insulin-resistance due to decreased expression from white adipose tissue (WAT). On the other hand, high levels of adiponectin are observed in lean and calorie-restricted (CR) states, surprisingly, without increased production from WAT. In this review, Authors Scheller, Burr, MacDougald, and Cawthorn discuss their research into this phenomenon, with the theory that bone marrow adipose tissue (MAT) is the actual source of CR-associated hyperadiponectinemia ().

Figure 1. Adiponectin expression in human femoral MAT. Scheller et al., p. 256.

Figure 1. Adiponectin expression in human femoral MAT. Scheller et al., p. 256.

Peri-pancreatic adipocyte inflammation and type 1 diabetes mellitus (T1DM)

pp. 270–274

In this review, authors Shao et al. present their recent studies into the increases in proinflammatory cytokine production in peri-pancreatic adipocytes (PATs) of small ubiquitin-like modifier (SUMO)-specific protease SENP-deficient mice. These cytokines are not only cytotoxic to pancreatic islets, but, also increases islet CCL5 expression inducing a state of chronic inflammation which contributes to T1DM.

The review further discusses how the biological functions of cellular proteins can be modulated by SUMO, known as SUMOylation, and the various aspects of this processes that may be associated with T1DM susceptibility ().

Figure 2. Model for the role of SENP1 in T1DM. Shao et al., p. 273.

Figure 2. Model for the role of SENP1 in T1DM. Shao et al., p. 273.

Adipocytes, adipose stem cells and chronic inflammation

pp. 275–282

Having recently shown that a pro-inflammatory environment can be induced by co-culturing peripheral blood mononuclear cells (MNC) with adipose tissue-derived stem cells (ASC) from obese donors, authors Chehimi et al. present new findings in this research paper related to inflammatory potential of differentiated adipocytes from adipose tissues of obese subjects. Through an analysis of blood MNC activation in co-culture assays with differentiated adipocytes, the authors demonstrate a pattern of proinflammatory activation similar to that of ASCs, with, increased secretion of IL-17A, IL-1β, and IL-6. These findings support the idea that both ASC and adipocytes contribute to the state of obesity-associated low-grade chronic inflammation via induction of Th-17 cells and activation of monocytes ().

Figure 3. Generation of differentiated adipocytes from ASC derived from subcutaneous AT of obese donors. Chehimi et al., p. 277.

Figure 3. Generation of differentiated adipocytes from ASC derived from subcutaneous AT of obese donors. Chehimi et al., p. 277.

A more detailed look into MicroRNA's adipogenesis regulation

pp. 283–297

The non-coding RNA's known as MicroRNAs may play a part in controlling adipogenesis and are able to regulate gene expression. However, few investigations have identified and expanded on microRNA's role on adipogenesis. Here, authors Rockstroh et al. used microarray-analysis in order to pinpoint exactly what microRNA was involved in human adipogenesis regulation. Their research led them to miR125b-5p, which during adipocyte differentiation was upregulated, and which in turn downregulated matrix metalloproteinase 11, an anti-adipogenic mediator (MMP11). Combined with the findings that miR125b-5P can directly inhibit adipogenesis, there is evidence that miR125b-5P may be used through MMP11 and other targets to affect human adipogenesis ().

Figure 4. Schematic overview of adipogenesis regulation by miR125b-5p. Rockstroh et al., p. 292.

Figure 4. Schematic overview of adipogenesis regulation by miR125b-5p. Rockstroh et al., p. 292.

Cortisone's regulatory properties on HSD1 and AQP7

pp. 298–305

Glucocorticoids (GC) regulate adipose tissue function and contribute to obesity-associated metabolic disease. Tissue activation of GCs occurs via 11 β-Hydroxysteroid dehydrogenase (Hsd1), and, overexpression of Hsd1 results in obesity whereas its deficiency protects against high fat diet-induced obesity and hyperglycemia. Adipocyte membrane-localized Aquaporin 7 (Aqp7), mobilizes H2O and glycerol, and, competes with Hsd1 in adipocyte triglyceride metabolism. The synthetic steroid dexamethasone (DXM) downregulates Aqp7 and induces differentiation of 3T3-L1 adipocytes. This brief report by Quesada-López, González-Dávalos, Piña, and Mora compares the action of cortisone on Hsd1 and Aqp7 expression in 3T3-L1 adipocytes. The authors observed immediate and parallel mRNA expression for both Hsd1 and Aqp7 in response to cortisone, as opposed to their hypothesis that cortisone reduces Aqp7 expression while favoring Hsd1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.